Opioids: Parasitic Worm Discovery Could Lead to Safer Painkillers
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The evolutionary trick of parasitic worm that sneakily burrows into the skin of its victims could provide new alternatives to opioid-based pain treatments.
Opioids are currently used to treat moderate to severe pain, as well coughing and diarrhea. Although they can provide effective relief, long-term use can also lead to dependence, with negative physical and mental health consequences.
Researchers discovered that the worm—Schistosoma mansoni—suppresses neurons in the skin to evade detection in a mechanism likely developed to enhance its own survival.
The molecules responsible for this suppression of sensation could help in the development of new painkillers, according to the team at the Tulane School of Medicine.
Schistosomiasis is a parasitic infection caused by helminths, a type of worm known to survive in their mammal hosts for many years. Their larvae can infest freshwater bodies like lakes, ponds and rivers—infecting people who, for example, swim, fish or wash clothes in the water.
"While bacteria often cause painful cutaneous reactions, host skin invasion by the human parasitic helminth Schistosoma mansoni often goes unnoticed," the researchers wrote in their paper.
Medical microscopy showing parasite.
Medical microscopy showing parasite.
defun/Getty Images
S. mansoni often evades detection by the immune system, unlike other bacteria or parasites that cause pain, itching or rashes—a feat the team set out to investigate.
After conducting experiments on mice, the researchers found that S. mansoni produces molecules that suppress the activity of TRPV1+, a protein used to send signals that the brain interprets as heat, itching or pain.
As part of the pain-sensing process in sensory neurons, TRPV1+ regulates immune responses in scenarios including allergy, autoimmunity, cancer, infection and even hair growth, the researchers explained.
It is likely the parasitic worm evolved its ability to block TRPV1+ because it enhance its survival, the researchers said.
"If we identify and isolate the molecules used by helminths to block TRPV1+ activation, it may present a novel alternative to current opioid-based treatments for reducing pain," said paper author and immunologist professor De'Broski R. Herbert| in a statement.
"The molecules that block TRPV1+ could also be developed into therapeutics that reduce disease severity for individuals suffering from painful inflammatory conditions."
Open spillage bottle of opioid pain killing tablets.
Open spillage bottle of opioid pain killing tablets.
BackyardProduction/Getty Images
The study also revealed that TRPV1+ is necessary for initiating host protection against S. mansoni. Activation of the protein leads to rapid mobilization of immune cells, including gd T cells, monocytes and neutrophils, which induce inflammation.
This inflammation, the researchers explained, plays a crucial role in host resistance to the larval entry into the skin.
These findings highlight the importance of neurons that sense pain and itching in successful immune responses.
"Identifying the molecules in S. mansoni that block TRPV1+ could inform preventive treatments for schistosomiasis. We envision a topical agent which activates TRPV1+ to prevent infection from contaminated water for individuals at risk of acquiring S. mansoni," said Herbert.
In the study, mice were infected with S. mansoni and evaluated for their sensitivity to pain as well as the role of TRPV1+ in preventing infection.
"S. mansoni infection significantly reduced thermal pain sensitivity evoked by TRPV1+ neurons. Consistently, isolated skin sensory neurons from infected mice had significantly reduced calcium influx and neuropeptide [chemical messenger] release in response to the TRPV1 agonist capsaicin [an irritant for humans and mammals] compared to neurons from naïve controls," the study authors wrote.
"Using gain-and loss-of-function approaches to test whether TRPV1+ neurons initiate host-protective responses revealed that TRPV1+ neurons limit S. mansoni skin entry and migration into the pulmonary tract."
The researchers are now planning to identify the nature of the secreted or surface-associated helminth molecules that are responsible for blocking TRPV1+ activity and specific gd T cell subsets that are responsible for immune responses. They also seek to further understand the neurons that helminths have evolved to suppress.
Newsweek has reached out to the researchers for additional comment.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question about opioids? Let us know via health@newsweek.com.
Reference
Inclan-Rico, J. M., Stephenson, A., Napuri, C. M., Rossi, H. L., Hung, L.-Y., Pastore, C. F., Luo, W., & Herbert, D. R. (2025). TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf141
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
an hour ago
- Newsweek
Obesity Before Pregnancy Linked to Autism-Like Behavior in Kids
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A mother's weight before pregnancy could be linked to autism-like behaviors in her children. This is the conclusion of a study by researchers at the University of Hawaiʻi at Mānoa, who found that obesity can trigger metabolic shifts that cause lasting epigenetic changes in a mother's eggs. These changes are passed on to the developing embryo and affect genes involved in brain development, including "Homer1," a protein important for regulating synaptic signaling, learning, memory and response to neural activity. Obesity and autism spectrum disorder (ASD) rates are increasing worldwide (though for autism this could be because of increased awareness). More than 2 in 5 adults (42.4 percent) are diagnosed as obese in the U.S., while 1 in 31 children and 1 in 45 adults are living with ASD across the country. While ASD is not an illness—and just means people's brains work differently from others'—the researchers said their findings mark a "significant advancement" in understanding how early life factors can shape long-term brain development. Excited young woman covering her mouth and screaming while looking at a positive pregnancy test in the bedroom. Excited young woman covering her mouth and screaming while looking at a positive pregnancy test in the bedroom. Antonio_Diaz/Getty Images Conducting experiments in mice models, the team detected increased levels of a specific Homer1 gene isoform that is known to interfere with neural connections—and is associated with behaviors linked to ASD—in male offspring of obese female mice. "This work highlights how a mother's health prior to pregnancy, not just during gestation, can shape her child's brain development in profound ways," said paper author and epigeneticist professor Alika K. Maunakea in a statement. "We were surprised to find that even without direct maternal contact after conception, these epigenetic imprints from the egg carried enough weight to alter behavior." To isolate the effects of pre-pregnancy obesity away from those during gestation, the time between conception and birth, the researchers used an in vitro fertilization (IVF) and embryo transfer model. This approach allowed them to study early epigenetic programming more precisely. Behavioral assessments of adolescent male mice revealed impaired social interactions and repetitive behaviors. These traits, which mirror characteristics of ASD, were linked to altered gene regulation in the brain, the researchers explained. "By leveraging our institute's expertise in developmental biology, reproductive science and epigenetics we are beginning to understand how early-life programming can ripple through generations," said paper author and reproductive biologist professor Monika Ward in a statement. The researchers say the findings may lead to early interventions, potentially even before conception. However, they hope future studies will explore nutritional or pharmacological therapeutic strategies that may reverse or mitigate these effects. There is no single known 'cause' for autism, but research suggests it could develop from a combination of genetic and environmental factors. "Brain scans show differences in the shape and structure of the brain in people with autism compared to in neurotypical development. Researchers do not know the exact cause of autism but are investigating a number of theories, including the links among heredity, genetics, and medical problems," the Autism Society website outlines. "There has been misinformation about the cause of autism. It is not caused by vaccines or due to parenting style or nutrition." Newsweek has reached out to the researchers for additional comment. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about autism? Let us know via health@ Reference Allan, N. P., Torres, A., Corley, M. J., Yamamoto, B. Y., Balaan, C., Yamauchi, Y., Peres, R., Qin, Y., Khadka, V. S., Deng, Y., Ward, M. A., & Maunakea, A. K. (2025). Pre-Conception Maternal Obesity Confers Autism Spectrum Disorder-like Behaviors in Mice Offspring Through Neuroepigenetic Dysregulation. Cells, 14(15), 1201.
Newsweek
2 hours ago
- Newsweek
Map Shows States With Most HPV-Related Cancers as 1 in 3 Unaware of Link
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. People in some U.S. states are more likely to be diagnosed with HPV-associated cancers than in others—with this discrepancy likely linked to awareness of the risk from the virus. Overall, one in three adults nationally are unaware of the connection between HPV and cancer, reveals a study from the MUSC Hollings Cancer Center in South Carolina. HPV, or the human papillomavirus, is spread by skin-to-skin contact and has been linked to the onset of six different types of cancer. It is responsible for almost all cases of cervical cancers, causes the majority of throat or 'oropharyngeal' cancers and can cause anal, penile, vaginal and vulvar cancers. "Awareness of HPV in the general population is an important determinant of preventative care uptake," MUSC researcher Kalyani Sonawane told Newsweek. Such measures, she explained, include the HPV vaccine and cervical cancers screening. "Achieving adequate HPV vaccine coverage is critical for eliminating these cancers." State-level data from the Centers for Disease Control and Prevention (CDC)—see map above—shows geographical differences in the diagnoses of HPV-associated cancers. At joint top of the list, Kentucky and West Virginia recorded 16.9 HPV-associated cancer cases per 100,000 residents in 2022 (the year with the most recent available data.) However, at the bottom of the list, North Dakota recorded just 8.3 HPV-associated cancer cases per 100,000 residents in the same year. According to the new study, around a third of Americans are not aware of either HPV or that a vaccine exists against it—despite this protection having been available for nearly two decades in the U.S. This lack of awareness is heightened in the Midwest and South, the researchers noted. For example, more than 40 percent of people in 13 states—including South Carolina—are unaware there is a vaccine against HPV. "In general, literacy levels (overall and health literacy) are lower in the U.S. South and Midwest, which is likely a reason why we found a lack of HPV awareness concentrated in states in these regions," explained Sonawane. The team used data from the Health Information National Trends Survey (HINTS), a survey conducted by the National Cancer Institute, to inform their research. Sonawane said that the CDC data "further highlights the need for increasing HPV awareness in Southern and Midwestern states"—where cases of HPV-related cancer also tend to be more common. The vaccine is the "first and best defense" against HPV-caused cancers, the researchers said. It is routinely recommended for children aged 11–12 years (and can be started as early as nine years). Catch-up vaccination is recommended through age 26. Additionally, adults aged 27–45 might be able to receive the vaccine after consultation with their healthcare provider. Doctor examining throat of male patient. Doctor examining throat of male research from Europe and the U.S. shows a significant reduction in cervical cancer cases in young women—likely due to them being the first group to have been vaccinated as children—there's a bigger picture to consider. Cervical cancer may show up when people are in their 30s or 40s, but oropharyngeal cancers are mostly diagnosed when people are in their 50s or 60s, the researchers warn. Sonawane noted that the biggest knowledge gap is in relation to oropharyngeal cancer. Across the nation, 70 percent of those who have heard about HPV did not know that it can lead to throat cancer. The vaccine is now approved for boys too, but their vaccination rates remain lower than among girls. "The HPV vaccine was first approved for the prevention of cervical cancer in women and was therefore heavily marketed toward women. This 'feminization' of the HPV vaccine continues to linger—and is likely a reason why most people have heard of HPV and cervical cancer, but not of its link with oral cancers," Sonawane explained. "Boys and men can also get HPV-associated oral, penile, and anal cancers; therefore, getting the HPV vaccine is equally important for males." While the pandemic interrupted measures of preventive care—including the HPV vaccination and screening for breast, cervical and colon cancers—an American Cancer Society report showed screening for breast and colon cancers has since rebounded. However, both cervical cancer screening—which is not a test for cancer, but a test to help prevent cancer—and HPV vaccination rates have not similarly recovered. "Prevention is always better than a cure. We have a safe and effective vaccine to prevent six cancers," Sonawane said. She concluded: "Going forward, we need to ensure that every child and eligible adult is protected from HPV-related cancers by ensuring they are offered the opportunity—i.e., the HPV vaccine—for preventing these cancers." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about HPV? Let us know via health@ Reference Garg, A., Damgacioglu, H., Graboyes, E. M., Seal, S., Deshmukh, A. A., & Sonawane, K. (2025). State-level public awareness of HPV, HPV vaccine, and association with cancer. JAMA Oncology. Star, J., Han, X., Smith, R. A., Schafer, E. J., Jemal, A., & Bandi, P. (2025). Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic. JAMA, 333(17), 1543–1546.
New York Post
3 hours ago
- New York Post
The rare disease tennis legend Monica Seles says had her seeing double on the court
Monica Seles, the nine-time Grand Slam champ who once dominated the court with her signature two-handed style, is facing a new kind of opponent — and this one isn't standing on the other side of the net. The 51-year-old International Tennis Hall of Famer recently revealed she's been quietly battling myasthenia gravis, a rare neuromuscular disease, for the past three years. 'It took me quite some time to really absorb it, speak openly about it, because it's a difficult one,' Seles told the Associated Press. 'It affects my day-to-day life quite a lot.' Advertisement 5 Monica Seles is a Serbian–American former professional tennis player who retired in 2008. Getty Images The tennis legend broke her silence just days before the 2025 US Open kicks off in Flushing Meadows, hoping to raise awareness about the chronic condition she'd never heard of until it landed in her own court. Here's everything you need to know. What is myasthenia gravis? Advertisement It's a rare autoimmune disorder that causes muscle weakness, often affecting those that control your eyes, face, neck, arms and legs, according to the Cleveland Clinic. The condition strikes when the body's immune system turns on itself, producing antibodies that block or destroy the receptor sites your muscles need to receive signals from the brain in order to move. With fewer working receptors, the message doesn't get through — leading to a communication breakdown between brain and body. As a result, the muscles feel weak and tire out fast, even from everyday tasks. 5 Myasthenia gravis causes muscle weakness that fluctuates and worsens with activity. buraratn – Advertisement What are the symptoms of myasthenia gravis? For more than half of those with the condition, the first signs affect the eyes, often causing double vision or drooping eyelids, per the Mayo Clinic. About 15% experience early symptoms that affect their face and throat muscles, which can: Make speech slurred or soft, sometimes sounding nasally, depending on which muscles are affected. Cause trouble chewing and swallowing, making it harder to eat, drink or take pills. Change facial expressions, like turning a smile into a snarl. Advertisement Myasthenia gravis can also weaken the neck, arms and legs, making it tough to lift things, walk steadily or even hold your head up. Seles first noticed that something was wrong when symptoms started showing up on the court. 5 Seles will make an appearance at the 2025 US Open to raise awareness about myasthenia gravis. Getty Images for American Express 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' she told the AP. Then came the muscle weakness. 'Just blowing my hair out … became very difficult,' the tennis champ said. The weakness usually worsens the more you use the affected muscles but can improve with rest, which can sometimes make diagnosis difficult. 'Patients can present with fatigue and then healthcare providers have no idea what to do with that,' Dr. Beth Stein, director of neuromuscular diseases at St. Joseph's Health in New Jersey, told The Athletic. Who's at risk for myasthenia gravis? Advertisement It can strike anyone, but it's most often diagnosed in women under 50 and men over 65, according to the Myasthenia Gravis Foundation of America. It's also slightly more common in people of African descent, though it affects all racial and ethnic backgrounds. 5 Drooping eyelids and a weakened smile are common symptoms of myasthenia gravis, often in the early stages of the disease. LIGHTFIELD STUDIOS – While still considered rare — affecting roughly 37 out of every 100,000 Americans — cases are on the rise. Experts believe this is at least partly because people are living longer lifespans and better tools have been developed to diagnose it. What's the outlook for someone with myasthenia gravis? Advertisement There's no cure, but the condition can usually be managed with treatment, especially if it's detected early, according to Johns Hopkins Medicine. Treatment may include medications that suppress the immune system or intravenous immunoglobulin, a blood product that helps reduce the attack on the nervous system. 5 Seles was diagnosed with the autoimmune disease three years ago. GC Images Advertisement Doctors might also remove the thymus gland surgically, which can sometimes improve symptoms by altering the immune response. Another option is plasmapheresis, a procedure that filters out abnormal antibodies from the blood and replaces them with healthy ones from donors. For Seles, every day is about adapting. 'Some days are very extreme,' she told the AP. Other days, she plays tennis, pickleball and walks her dogs. Advertisement 'As I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust,'' Seles said. 'And that's what I'm doing now.' Is myasthenia gravis fatal? Generally, no. Most people with myasthenia gravis have a normal life expectancy, but in rare cases, it can cause life-threatening complications. That includes myasthenic crisis, a severe weakening of the muscles that control breathing, which can lead to respiratory failure and other medical emergencies In such cases, a ventilator may be needed until muscle strength improves with treatment.
